Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV CongressSeptember 16, 2026
Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in ItalySeptember 15, 2026
Business Investcorp acquires industrial portfolio in WalesFebruary 14, 2021 Investcorp, a Bahrain-based asset manager that counts Mubadala Investment Company as its biggest shareholder, on Monday announced that one of…
